Connect with us

International

MLB trade rumors and news: Touki Toussaint shines in return to mound

Dale Zanine-USA TODAY SportsToussaint hadn’t yet pitched in 2020 as he recovered from a shoulder strain. The MLB Daily Dish is a daily feature we’re running here at MLBDD that rounds up roster-impacting news, rumors, and analysis. Have feedback or have…

Published

3 years ago

on

Dale Zanine-USA TODAY Sports

Toussaint hadn’t yet pitched in 2020 as he recovered from a shoulder strain.

The MLB Daily Dish is a daily feature we’re running here at MLBDD that rounds up roster-impacting news, rumors, and analysis. Have feedback or have something that should be shared? Hit us up at @mlbdailydish on Twitter or @MLBDailyDish on Instagram.

  • While he’s still just 25 years old, Touki Toussaint has had somewhat of a disappointing career. The 2014 first-rounder posted a combined 5.97 ERA over his first three major league seasons and had been sidelined through all of 2021 due to a shoulder strain. He made his season debut on Tuesday night, though, and he was very impressive, allowing one earned run on three hits and two walks over 6.2 innings. He’s very much still an unknown, but if Toussaint can consistently perform at that level, he’ll provide a major boost to a Braves rotation that has largely disappointed this season.
  • The Giants are “one of the key teams to watch” if Marlins center fielder Starling Marte is dealt before the deadline, per Craig Mish and Jordan McPherson of the Miami Herald. Marte’s numbers are roughly equivalent to those of Giants center fielder Steven Duggar, so he wouldn’t appear to provide a transformative upgrade. But if the asking price for the pending free agent is mild enough that San Francisco can acquire him as a right-handed hitting platoon option, perhaps there will be interest.
  • While the Marlins weren’t going anywhere this season, they clearly have formed an exciting young core of players that should be competitive in the National League East in the coming years who are fun to watch even now. Unfortunately, a chunk of that young core appear to be set to miss some time as Jazz Chisholm and Garrett Cooper hit the injured list after getting hurt in the exact same game.
  • Mets fans, don’t look: Jacob deGrom has hit the injured list with forearm tightness. New York has made it very clear that the time table on this injury is flexible, and deGrom won’t throw until that tightness has subsided. I don’t think I need to tell you how devastating this is for the Mets. Doctors are still doing tests to get to the root of what’s causing this.
  • The White Sox have signed Lance Lynn to a two-year, $38 million extension with a club option for 2024. In ten seasons, Lynn has been a solid rotation staple, but this season feels like the comeback most players only dream of. So far in 2021, the veteran is hurling a 1.99 ERA with 105 strikeouts, and only 31 walks over 90.2 innings. Talk about getting your money’s worth.
  • The Braves’ outfield has been ravaged by injuries and/or legal issues this season. With prospects Drew Waters and Cristian Pache still getting work in the minor leagues, the Braves decided to make a move to shore that unit up as they acquired Joc Pederson from the Cubs for 1B prospect Bryce Ball.
  • But the Braves weren’t done wheeling and dealing quite yet. They then acquired Stephen Vogt from the Diamondbacks, securing another strong leadership presence in the dugout. In return, Atlanta will send 25-year old first base prospect Mason Berne to Arizona.
  • In a reminder that COVID-19 is an ever-present threat especially with new variants emerging, the Yankees have themselves a bit of an outbreak on their roster despite multiple players involved being vaccinated. Thursday’s Yankees-Red Sox game was postponed as they had three players test positive and three more were placed in health protocols.
  • Shohei Ohtani threw a perfect first inning to earn the win and Vladimir Guerrero Jr. hit an absolute moonshot in the third inning as the American League earned its eight straight All-Star victory in last week’s Midsummer Classic. The 22-year-old Guerrero, who had two RBI, became the youngest player ever to earn All-Star MVP honors.
  • Encouraging news for baseball fans who don’t like the major rule changes instituted over the last two seasons: Rob Manfred says that seven-inning doubleheaders and the runner-on-second rule in extra innings are unlikely to survive beyond the 2021 season, with Manfred saying those changes were instituted for the purpose of limiting time at the ballpark during the COVID-19 pandemic — something that isn’t expected to be a factor in future seasons.
  • In what turned out to be a really great Home Run Derby with multiple mini-storylines, the final came down to Trey Mancini vs. reigning champ Pete Alonso. When Mancini put up an astonishing 22 home runs in the final round, it looked like it very possible that the cancer survivor would take home the hardware in an upset. However, Alonso flipped a switch and took home the win with 23 home runs (despite his BP pitcher hitting him with a pitch).
  • Amidst the draft still going on and the All-Star festivities, MLB announced that over the course of the next decade, they are going to donate up to $150 million to the Players’ Alliance. The Players’ Alliance is an organization that seeks to increase the amount of representation and access for Black people to the sport of baseball. Count us among those that say well done, MLB...but there is a lot of work to do.
  • The 2021 MLB Draft started up on Sunday, and to say that it was a wild round one may be a bit of any understatement as mock drafts were blown up within the first five picks. That started with the number one overall pick as Henry Davis was chosen by the Pittsburgh Pirates in a bit of an upset.
  • In devastating news for Braves fans, Ronald Acuña Jr. was injured when trying to make a play on a fly ball. None of the aftermath looked good as Acuña was unable to finish leaving the field and had to be carted off with an apparent knee injury. Sadly, he did not escape major injury this time as it was confirmed that he completely tore his ACL and will miss the remainder of the season.
  • Trevor Bauer remains under investigation after being accused of sexual assault, and to allow time for that investigation to complete, his administrative leave was extended by another seven days. If the investigation is not completed by then, the notion of an indefinite suspension is most definitely on the table.
  • White Sox catcher Yasmani Grandal will miss the next 4-6 weeks with a torn tendon in his left knee. That’s rough news for a team that is already missing Nick Madrigal, Eloy Jiménez, and Luis Robert, though Chicago still has a lot of breathing room in a bad AL Central.
  • Whether it’s Prince Fielder, Jesús Aguilar, and Daniel Vogelbach, the Brewers love themselves a hefty slugging first baseman, and they added another one on Tuesday, acquiring Rowdy Tellez from the Blue Jays in exchange for reliever Trevor Richards. The 26-year-old Tellez had an up-and-down four-year tenure with Toronto but proved he could succeed at the major league level, hitting 21 homers in 2019 and posting a 140 OPS+ last year. Tellez struggled to a .610 OPS this season and had twice been demoted to Triple-A, but it appears he’ll initially join Milwaukee’s major league club.
  • Sixto Sanchez came into the 2021 season as a guy who was on most people’s shortlists of guys that could win National League Rookie of the Year. Unfortunately, the injury bug bit him and instead of trying to help the Marlins climb out of the cellar of the NL East, he is going to miss the rest of the season after undergoing shoulder surgery.
  • The Nationals are having a rough past couple of days, as both Kyle Schwarber and Alex Avila have been placed on the 10-day IL. Schwarber, who thankfully won’t need surgery, will sit after suffering a right calf strain running to first last Friday. The timetable for his return has yet to be set, and the first-time All-Star will almost absolutely miss the game. Gerardo Parra will play left field in his absence. Avila will miss time because of bilateral calf strains.
  • Mariners lefty Héctor Santiago is the first pitcher to be disciplined as part of MLB’s foreign substance crackdown after being ejected when umpires believed they found a foreign substance on his glove. Santiago admitted to having rosin on his glove, and while it wasn’t a highly-publicized element of the new policy, pitchers are now strictly prohibited from having rosin on their person, even though they are allowed to obtain it from the bag on the mound. MLB confiscated Santiago’s glove but never examined it, and now they’ve hit him with a 10-game suspension and undisclosed fine.
  • The Blue Jays are determined to reach the playoffs for a second straight season, and they boosted their roster by acquiring sidearming reliever Adam Cimber and currently injured outfielder Corey Dickerson from the Marlins in exchange for veteran utility player Joe Panik and relief prospect Andrew McInvale.
  • Braves starter Mike Soroka has re-ruptured his Achilles and will not pitch again in 2021. After making three starts in 2020, he tore his Achilles. He hadn’t pitched since then. Soroka looked like he’d be the Braves’ ace for years to come after going 13-4 with a 2.68 ERA, 1.11 WHIP, and .236 OBA in 2019, but now his future is extremely uncertain.
  • The Blue Jays have signed veteran reliever John Axford, reports Jamie Campbell of Sportsnet. The 38-year-old hasn’t seen a major league mound since 2018 and had been working as an analyst on the Jays’ pre and postgame shows before being asked to pitch for them again. The bulk of his career came with the Brewers, as he played in Milwaukee from 2009-13, but now the Ontario native will embark on his third stint with Toronto.
  • Rays ace Tyler Glasnow’s season is in jeopardy after he suffered a partially torn UCL and flexor strain in his right arm. He’ll initially try to rehab the injuries rather than immediately opting for Tommy John surgery. In an interesting crossover with the biggest story being discussed around baseball right now, Glasnow said MLB’s crackdown on foreign substances contributed to his injury, as he stopped using a mixture of sunscreen and rosin, and as a result he began gripping the baseball so hard that he injured his elbow.
  • A lot has been made in recent weeks about the proliferation of foreign substances used primarily (but certainly not exclusively) by pitchers to get better grip on balls to have better command as well as to generate greater spin. It has been clear that MLB was going to crack down on the practice and now it looks like it has landed on its chosen punishment, as it was announced that players found to be using such substances will receive a 10-game paid suspension.

Read More

Related Topics:
Continue Reading

International

IVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets

  Credit: IVI IVI will complete the technology transfer by 2025 Oral Cholera Vaccine to be manufactured by Biological E. Limited for India and international…

Published

6 hours ago

on

March 20, 2024

By

 

Credit: IVI

  • IVI will complete the technology transfer by 2025
  • Oral Cholera Vaccine to be manufactured by Biological E. Limited for India and international markets

 

March 20, 2024, SEOUL, Republic of Korea and HYDERABAD, India — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, today announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company.

 

Following the signing of a technology license agreement in November last year, IVI has begun providing the technical information, know-how, and materials to produce OCV-S at BE facilities and will continue to support necessary clinical development and regulatory approvals. IVI and BE entered this partnership during an unprecedented surge of cholera outbreaks worldwide and aim to increase the volume of low-cost cholera vaccine in India as well as the global public market.

 

IVI will complete the technology transfer by 2025 and the oral cholera vaccine will be manufactured for India and international markets by Biological E. Limited.

 

Dr. Jerome Kim, Director General of IVI, said: “In an era of heightened risk of poverty-associated infectious diseases such as cholera, the world needs a sustainable source of high-quality, affordable vaccines and committed manufacturers to supply them. We are pleased to partner with Biological E., a company with a proven history of making life-saving vaccines accessible globally, to address this supply gap and protect communities from this deadly, though preventable, disease.”

 

Ms. Mahima Datla, Managing Director, Biological E. Limited, said: “We are glad to be in collaboration with IVI for the manufacture of simplified Oral Cholera Vaccine. Our efforts are aimed to not only combat the disease but to also be part of a sustained legacy of innovation, collaboration, and health stewardship. Together with IVI, we are happy to be shaping a healthier and more resilient future by making this vaccine accessible globally.”

 

This technology transfer and licensing agreement is the sixth of its kind for IVI, transferring such technology to manufacturers in India, the Republic of Korea, Bangladesh, and South Africa. All these partnerships have led to or seek to achieve, pre-qualification (PQ) from the World Health Organization, a designation that enables global agencies such as UNICEF to procure the vaccine for the global market. BE already has 9 vaccines with WHO PQ in its portfolio, and IVI and BE will pursue WHO PQ for OCV-S as well, following national licensure in India.

 

Dr. Julia Lynch, Director of IVI’s Cholera Program, said: “The cholera situation is dire, and the availability and use of oral cholera vaccine is an essential part of a multifaceted approach to cholera control and prevention, especially as outbreaks increase and the global vaccine supply remains strained. With more manufacturers like BE entering the market, the future supply situation looks strong. IVI remains committed to ensuring the availability of the oral cholera vaccine and to developing new and improved vaccines that are equally safe, effective, and affordable and made around the world, for the world.”

 

OCV-S is a simplified formulation of OCV with the potential to lower production costs while increasing production capacity for current and aspiring OCV manufacturers. IVI’s development of OCV-S and ongoing technology transfers are part of an institutional strategy to confront cholera with 3 main goals: 1) Ensure supply of OCV 2) Improve cholera vaccines 3) Support OCV use and introduction. The Bill & Melinda Gates Foundation has been supporting IVI’s cholera program since 2000 and is funding this latest technology transfer to BE.

 

###

 

About the International Vaccine Institute (IVI)

The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO), and developed a new-generation typhoid conjugate vaccine that also achieved WHO prequalification in early 2024.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, an Africa Regional Office in Rwanda, a Country Office in Austria, and a Country and Project Office in Kenya. IVI additionally co-founded the Hong Kong Jockey Club Global Health Institute in Hong Kong and hosts Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

 

About Biological E. Limited

Biological E. Limited (BE), a Hyderabad-based Pharmaceuticals & Biologics Company founded in 1953, is the first private sector biological products company in India and the first pharmaceutical company in Southern India. BE develops, manufactures and supplies vaccines and therapeutics. BE supplies its vaccines to more than 130 countries and its therapeutic products are sold in India, the USA and Europe. BE currently has 8 WHO-prequalified vaccines and 10 USFDA approved Generic Injectables in its portfolio. Recently, BE has received Emergency Use Listing (EUL) from the WHO for CORBEVAX®, the COVID-19 vaccine. Recently, DCGI has approved BE’S 14-Valent Pneumococcal Conjugate vaccine.

In recent years, BE has embarked on new initiatives for organizational expansion such as developing specialty injectable products for global markets as a means to manufacture APIs sustainably and developing novel vaccines for the global market.

Please follow us on Facebook, LinkedIn and Twitter

 

 

MEDIA CONTACTS

IVI

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int

 

Biological E. Limited

K. Vijay Amruth Raj
Email: Vijay.Kammari@biologicale.com
www.biologicale.com/news

Read More

Continue Reading

Government

Bolsonaro Indicted By Brazilian Police For Falsifying Covid-19 Vaccine Records

Bolsonaro Indicted By Brazilian Police For Falsifying Covid-19 Vaccine Records

Federal police in Brazil have indicted former President Jair…

Published

21 hours ago

on

March 19, 2024

By

Bolsonaro Indicted By Brazilian Police For Falsifying Covid-19 Vaccine Records

Federal police in Brazil have indicted former President Jair Bolsonaro for falsifying his Covid-19 vaccine card in order to travel to the United States and elsewhere during the pandemic.

Federal prosecutors will review the indictment and decide whether to pursue the case - which would be the first time the former president has faced criminal charges.

According to the indictment, Bolsonaro ordered a top deputy to obtain falsified Covid-19 vaccine records of himself and his 13-year-old daughter in late 2022, right before he flew to Florida for a three-month stay following his election loss.

Brazilian police are also waiting to hear back from the US DOJ on whether Bolsonaro used said cards to enter the United States, which would open him up to further criminal charges, the NY Times reports.

Bolsonaro has repeatedly claimed not to have received the Covid-19 vaccine, but denies any involvement in a plan to falsify his vaccination records. A previous investigation by Brazil's comptroller general concluded that Bolsonaro's vaccination records were false.

The records show that Bolsonaro, a COVID-19 skeptic who publicly opposed the vaccine, received a dose of the immunizer in a public healthcare center in Sao Paulo in July 2021. [ZH: hilarious, Reuters calling the vaccine an 'immunizer.']

The investigation concluded, however, that the former president had left the city the previous day and didn't leave Brasilia until three days later, according to a statement.

The nurse listed in the records as having applied the vaccine on Bolsonaro denied doing so and was no longer working at the center. The listed vaccine lot was also not available on that date, the comptroller general's office said. -Reuters

"It's a selective investigation. I'm calm, I don't owe anything," Bolsonaro told Reuters. "The world knows that I didn't take the vaccine."

During the pandemic, Bolsonaro panned the vaccine - and instead insisted on alternative treatments such as Ivermectin, which has antiviral properties against Covid-19. For this, he was investigated by Brazil's congress, which recommended that the former president be charged with "crimes against humanity," among other things, for his actions during the pandemic.

In May, Brazilian police raided Bolsonaro's home, confiscating his cell phone and arresting one of his closest aides and two of his security cards in connection to the vaccine record investigation.

Brazil's electoral court ruled that Bolsonaro can't run for public office until 2030 after he suggested that the country's voting system was rigged. For that, he has to sit out the 2026 election.

Tyler Durden Tue, 03/19/2024 - 11:00

Read More

Continue Reading

International

This gambling tech stock is future-proofing the world’s casinos

Supported by the universal thrill of a quick payout and the need for leisure, gambling stocks make a compelling case for long-term returns.
The post This…

Published

21 hours ago

on

March 19, 2024

By

Supported by the universal human thrill of a quick payout, and the need for leisure and entertainment to bring enjoyment to adult life, casinos will remain essential spaces for people to dream and play for the foreseeable future, making gambling stocks a prospective space to look for long-term returns.

According to Research and Markets, the global casino industry was valued at US$157.5 billion in 2022, and it will grow to US$224.1 billion by 2030 at a compound annual growth rate of 4.5 per cent. This trend includes:

Approximately 100 million gamblers in the United States, who generated US$66.5 billion in revenue in 2023, a 10 per cent gain from 2022, which itself was a record year A little fewer than 20 million gamblers in Canada, who generated about C$15 billion in revenue in 2023 A global addressable market of thousands of casinos, and more than 4.2 billion people who gamble at least once every year, according to a 2016 study by Casino.org

The main challenge with attracting these billions through casino doors is they sway heavily toward middle age. The mean age of U.S. casino visitors has hovered around 50 for the past decade, with a similar trend across the world, forcing casinos to attract younger, tech-savvy customers, many with less gambling experience, to continue growing profits for their stakeholders over the long term.

Investors seeking exposure to a leadership position in building the bridge between casinos and the next generation of gamblers should evaluate Jackpot Digital (TSXV:JJ). The Vancouver-based company is a manufacturer of dealerless electronic table games that deliver immersive experiences tailored to the digital age, while earning casinos attractive returns on investment.

The gambling technology stock benefits from no direct competition in the dealerless poker space, with orders spanning North America, Europe, Asia, Africa and the Caribbean, a long-established presence with major cruise ship brands, such as Carnival, Princess Cruises and Holland America, and a growing land-based presence with orders or ongoing installations across 12 U.S. states. Its highlight partnership to date is a master services agreement with Penn Entertainment, the country’s largest regional gaming operator with 43 properties across 20 states.

Jackpot Digital’s differentiated technology and well-rounded management team are at the heart of its success in landing several blue-chip casino gaming companies as customers.

Jackpot Blitz

The gambling technology stock’s flagship product, Jackpot Blitz, is a dealerless poker table featuring three of the world’s most popular variations – Texas Hold’ em, Omaha, and Five-Card-Omaha – brought to life through slick 4k graphics on a 75-inch touchscreen, and offered in three formats – pot-limit, no-limit and fixed-limit – designed to attract a diversity of revenue from casual to experienced players.

Spokesperson and NFL championship-winning coach Jimmy Johnson explains the benefits of the Jackpot Blitz. Source: Jackpot Digital.

The table also comes equipped with house-banked mini-games, including blackjack, baccarat and video poker, as well as side bets on the main poker game, such as Bet the Flop, all of which keep players engaged and entertained between, and even during, poker hands. The stunning Jackpot Blitz machine also offers multi-venue “Bad Beat” jackpot functionality, allowing casinos to offer a “Poker Powerball” with massive Jackpots, further enhancing the attractiveness of Jackpot Blitz to new players.

It’s by striking a balance between the needs of the modern gambler, and efficiency and profitability that in-person operators couldn’t hope to match – unless they ordered the machine for themselves – that Jackpot Digital has earned itself the top spot in dealerless poker.

Player benefits

When a veteran or novice gambler takes a seat at the Jackpot Blitz, his or her experience begins with an easy-to-use interface, laid out in a modern and stylish design, programmed to respond to hand gestures that bring real casino play into the digital age, including card bending and chip jingling.

Source: Jackpot Digital.

The table’s intuitive controls, combined with instant payouts and its dealerless nature, translate into faster game play, which maximizes playing time and player excitement, while minimizing human error and the intimidation new gamblers might feel about approaching an analog poker table. The gambling technology stock’s in-house development team is also constantly working on new games to keep content fresh, with a special focus on bringing international games and regional versions of poker to casino audiences in Asia, South America and the Indian subcontinent.

As hands are laid down and pots pile up, players can also track game stats in real time, which inform future strategy and enhance the thrill of the moment with an added element of competition.

Operator benefits

From an operator’s perspective, a floor of automated gaming tables can meaningfully and instantly reduce casino staff expenditures and management pain points, while avoiding wage inflation, labour shortages and supply costs.

The Blitz is no slouch on revenue either, dealing more hands per hour, resulting in higher revenue and higher profitability, which is further enhanced by onboard side bets and mini-games that can be played while players are engaged in a poker hand.

The Jackpot Blitz’s economics are attractive to operators thanks to its ability to accommodate non-stop play, while monetizing downtime through side games and bets. While a human dealer must spend time shuffling, interacting with players, and consulting with colleagues, the Jackpot Blitz can accept wagers 100 per cent of the time, making sure gamblers get the action they came for and operators see a return on their investment.

Source: Jackpot Digital.

Beyond gaming revenue, casinos are further incentivized to onboard the Jackpot Blitz because of its fully customizable advertising functions, including logos, card backs, chips and felt colors, all of which bolster casino culture and enable the pursuit of revenue from third-party advertising partners.

The Blitz ties its value proposition together by generating automatic reports – including demographics and consumer behaviour through a rewards card system – and plugging directly into most back-end management systems, saving casinos the hassle of manual tracking, while also minimizing tampering, money-laundering and theft through the use of isolated servers.

Whether it’s streamlining the player experience or putting automation at the service of operators’ bottom lines, Jackpot Digital’s flagship product is positioned to create value, and plenty of it.

Jackpot Digital’s path to profitability

After existing as an exclusively cruise-ship-based operation since 2015, Jackpot Digital suffered a steep decline in revenue during the COVID pandemic, falling from C$2.18 million in 2019 to C$0.42 million in 2021.

Management quickly pivoted in the face of uncertainty, redesigning the Blitz to execute on a land-based expansion strategy – backed by Gaming Labs International certification in fall 2023 – which is bringing about a successful turnaround after the re-emergence of the casino business. Revenue more than tripled to C$1.43 million in 2022, and reached C$1.57 million through three quarters of 2023, with the company expecting to ramp up significant recurring revenue after it installs several dozen machines currently in its backlog.

The Jackpot Blitz electronic gaming table in action. Source: Jackpot Digital.

The first installation of land-ready Jackpot Blitz machines is now completed at the Jackson Rancheria Casino in California, as the company announced today. The three-machine installation marks a new era of growth for the company, having announced 25 Blitz deals since November 2021 (slide 12), with many more across Canada and the United States in the works, in addition to a strong pipeline in Asia and Europe.

“Jackpot Digital could be a profitable company right now if it only focused on care and maintenance of the revenues it currently generates. But that’s not why we’re here,” Mathieu McDonald, Vice President of Corporate Development at Jackpot Digital, said in a recent interview with Stockhouse. “We intend to scale up to many multiples of the tables we have out right now, with the potential for up to 2,000 tables over the next three to five years.”

According to McDonald, the company is fielding three to five inquiries per week about the Blitz from casinos around the world that recognize the machines’ first-mover advantage in dealerless poker and potential expansion into other games in need of automation.

Jackpot Digital’s ambitious plan of action is supported by a management team of proven gambling, finance, advertising and legal professionals, many of which have been serving Jackpot stakeholders for more than two decades.

A long-tenured management team

The management team behind Jackpot Digital is led by Jake Kalpakian, who has served as president and chief executive officer since 1999, including under the gambling technology stock’s former incarnation as Las Vegas From Home.com Entertainment Inc. Kalpakian brings more than 30 years of experience managing small-cap publicly listed companies, granting him a steady hand when it comes to maneuvering through the volatility of the economic cycle.

Kalpakian’s efforts are supported by three directors whose well-rounded expertise positions Jackpot Digital for long-term sustainable growth:

Gregory T. McFarlane, a director at Jackpot Digital since 1999, previously ran an independent advertising firm and holds a degree in mathematics from the University of Toronto. McFarlane is also a co-founder of the popular Control Your Cash personal finance website. Chief financial officer Neil Spellman, a director at the company since 2002, boasts an almost two-decade track record as vice president at Wall Street firm Smith Barney, where he developed a multi-industry understanding of the journey to profitability. Finally, Alan Artunian, a director since 2017, currently serves as CEO of Nice Guy Holdings, a corporate and legal consulting company advising clients across a diversity of sectors.

Guided by a strategic management team, and benefiting from a macro-trend toward casino automation, Jackpot Digital is on course to ride a wave of millions of gamblers looking for an elegant, tech-informed alternative to traditional in-person play.

A multi-bagger opportunity

The Jackpot Digital opportunity sets up savvy investors who recognize the soundness of the company’s value proposition. The tremendous risk/reward value of Jackpot Digital gives investors the opportunity to ride the macro-trend toward casino automation, as deals for the Blitz keep pouring in, the company adds games to its portfolio, and the global casino industry adds hundreds of billions in revenue through this decade.

Join the discussion: Find out what everybody’s saying about this gambling technology stock on the Jackpot Digital Bullboard.

This is sponsored content issued on behalf of Jackpot Digital, please see full disclaimer here.

The post This gambling tech stock is future-proofing the world’s casinos appeared first on The Market Online Canada.

Read More

Continue Reading

Trending